Day: September 26, 2024

DALLAS, Sept. 26, 2024 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ: PMD), a global leader in hair testing for drugs of abuse, is excited to announce the release of its first-ever Education Insights Report. This report provides an in-depth analysis of drug trends within educational institutions, shedding light on the growing challenges schools face in maintaining a drug-free environment for students and staff. Following the success of our inaugural Workforce Insights Report earlier this year, we continue our commitment to providing groundbreaking insights based on data from hair testing. For the Education Insights Report, Psychemedics analyzed thousands of hair samples collected from students and staff in educational settings across the United States. The data offer valuable perspectives on drug use trends over the past...

VANCOUVER, British Columbia, Sept. 26, 2024 (GLOBE NEWSWIRE) — Finning International Inc. (TSX: FTT) (“Finning”, the “Company”, “we”, “our” or “us”) today announced an executive leadership team transition update as part of our succession planning process and to accelerate the execution of our strategic plan. Finning places significant value on succession planning and smooth leadership transitions. As we expand our planning horizons, it is important to ensure the renewal of our executive team and that we have our best talent deployed to the biggest opportunities. Tim Ferwerda, current managing director of Finning UK and Ireland, will transition to the role of president of Finning Canada. David Primrose, current president of Finning Canada, will support Tim’s transition and assume the role of executive vice president and chief development...

US Bankruptcy Court for the Southern District of Texas issued an order to extend the lock-up period on the Scilex Dividend Stock, previously distributed by Sorrento, to January 31, 2025. Accordingly, any shares of the Dividend Stock (including any such shares held by brokerage firms) may not be sold, transferred or otherwise disposed of. Scilex’s transfer agent, Continental Stock Transfer & Trust Company, has been notified of the lock-up extension to January 31, 2025.PALO ALTO, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today announced that the U.S. Bankruptcy Court for the Southern District of Texas...

Appointment indicates Hapbee’s commitment to expand in the Middle East and globally MONTRÉAL, Sept. 26, 2024 (GLOBE NEWSWIRE) — CNW Telbec/ – Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) (“Hapbee” or the “Company”), a leading provider of wellness wearable technology, is pleased to announce that Mr. Abdulla Al Zain has been appointed as an additional director on the Board effective September 16th, 2024. Mr. Al Zain succeeds Robert Dzisiak, who has served as a member of the Board since Hapbee’s inception. The company thanks Mr. Dzisiak for his service. Mr. Abdulla Al Zain brings a wealth of experience across a number of critical asset classes for Hapbee, such as hospitality, sports and financial services, particularly across Europe and the Middle East. He is the Chairman and...

Campaign Fortifies Company’s Two Decades of Industry-Defining Diamond LeadershipThe Jane Goodall Collection from Brilliant EarthDr. Jane Goodall in the Jane Goodall Collection Pavé Leaf Lab Diamond Pendant NecklaceSAN FRANCISCO, Sept. 26, 2024 (GLOBE NEWSWIRE) — Brilliant Earth Group, Inc. (“Brilliant Earth” or the “Company”) (Nasdaq: BRLT), an innovative, global leader in ethically sourced fine jewelry, today announced the launch of the “Rethink Everything You Know About Diamonds” campaign, featuring the debut of The Jane Goodall Collection. A continuation of the Company’s partnership with iconic conservationist Dr. Jane Goodall, the collection underscores Brilliant Earth and Dr. Jane Goodall’s collective vision of environmental stewardship. The “Rethink Everything You Know About Diamonds” campaign invites consumers...

— Customers including Fireworks AI are powering their AI inference and training workloads with new OCI Compute instances — — OCI Supercluster leads among cloud providers with support for up to 16,384 AMD Instinct MI300X GPUs in a single ultrafast network fabric — SANTA CLARA, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) —  AMD (NASDAQ: AMD) today announced that Oracle Cloud Infrastructure (OCI) has chosen AMD Instinct™ MI300X accelerators with ROCm™ open software to power its newest OCI Compute Supercluster instance called BM.GPU.MI300X.8. For AI models that can comprise hundreds of billions of parameters, the OCI Supercluster with AMD MI300X supports up to 16,384 GPUs in a single cluster by harnessing the same ultrafast network fabric technology used by other accelerators on OCI. Designed to run demanding...

September 26, 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Interim results for the six months ended June 30, 2024 Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, today announces its unaudited interim results for the six months ended June 30, 2024 which will also be made available on the Company’s website at www.biodexapharma.com OPERATIONAL HIGHLIGHTS The Company announced the following in the six months ended June 30, 2024:Exclusive worldwide licensing of eRapa™, a Phase 3 ready asset with a lead indication of Familial Adenomatous Polyposis (“FAP”) together with access to a $17 million grant.Six month data of eRapa in FAP showing an 83% non-progression...

HOUSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) — Impact BioMedical Inc. (“IBO”) is pleased to announce that the US Patent and Trademark Office has issued U.S. Patent No. 11,985,973 entitled “Insect Repelling Composition” developed within IBO’s 3F™ technology platform. This is in addition to IBO’s prior granted U.S. Patent No. 11,246,310. Both patents include compositions and formulations of constituents found in plants and fragrances produced by plants, which, when applied as a natural insect repellent, have the potential to reduce insect landings and bites experienced in an outdoor environment. The terms of U.S. Patents 11,985,973 and 11,246,310 will expire in February 2039 and April 2040, respectively. This expands Impact BioMedical’s 3F™ patent estate, which includes insect repellent compositions and anti-microbial applications...